跳至主要内容
临床试验/JPRN-UMIN000026739
JPRN-UMIN000026739已完成2 期

The efficacy and safety of antiemetic therapy for carboplatin-containing chemotherapy-induced nausea and vomiting in patients with lung cancer. - Antiemetic therapy for carboplatin-containing chemotherapy-induced nausea and vomiting.

Second Division, Department of Internal Medicine, Hamamatsu university school of medicine0 个研究点目标入组 30 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)patients with the history of hypersensitivity or allergy for study drugs. 2)patients who need and use antiemetic therapy during 48h before chemotherapy. 3)patients with severe hepatic or renal dysfunction. 4)With convulsion. 5)Patients who need puncture to manage ascites. 6)Patients with complications inducing nausea and vomiting. 7)Patients with diabetes mellitus. 8)Patients who are judged to be inappropriate for this study.

研究者

发起方
Second Division, Department of Internal Medicine, Hamamatsu university school of medicine

相似试验